What is it about?
We cover identifying and stratifying risk for TD during routine examination, evidence-based strategies and tools for the diagnosis of patients with TD, formulating individualized treatment plans for patients with tardive dyskinesia.
Featured Image
Why is it important?
We owe our patients the aspirational goal of striving for zero prevalence of persistent symptoms of TD in anyone treated for psychosis.
Perspectives
Despite recent progress, many questions remain for future research including the mechanisms underlying TD, genetic predisposition, phenomenological diversity, whether new cases are reversible, how to implement best practices to prevent and treat TD, and whether the development of novel antipsychotics free of the risk of TD is attainable.
Dr. Stanley N. Caroff
University of Pennsylvania
Read the Original
This page is a summary of: A new era in the diagnosis and treatment of tardive dyskinesia, CNS Spectrums, October 2022, Cambridge University Press,
DOI: 10.1017/s1092852922000992.
You can read the full text:
Contributors
The following have contributed to this page
